Results 181 to 190 of about 118,238 (222)

Structure-Guided Design of Novel Diarylpyrimidine-Based NNRTIs Through a Comprehensive In Silico Approach: 3D-QSAR, ADMET Evaluation, Molecular Docking, and Molecular Dynamics. [PDF]

Pharmaceuticals (Basel)
Baassi M, Moussaoui M, Rajkhowa S, Soufi H, Daoud R, Belaaouad S.   +5 more
europepmc   +1 more source

Recent Developments in HIV Antivirals: The Prospect of Prophylactic Drugs to Change the Pandemic. [PDF]

Microb Biotechnol
Brüssow H.
europepmc   +1 more source

Alternative Administration of Antiretroviral Therapy in People with HIV Unable to Swallow: A Scoping Review. [PDF]

HIV AIDS (Auckl)
Abdessamad H, Baroody C, Pogorzelski K, Jamaleddine W, Kitonga MS, Omar H, Amankrah SA, Allen-Brown K, Dandachi D.   +8 more
europepmc   +1 more source

HIV-1 subtype diversity trends in a Northern California cohort. [PDF]

AIDS
Tao K, Tzou PL, Sahoo MK, Hare CB, Pinsky BA, Shafer RW.   +5 more
europepmc   +1 more source

David Baltimore: Scientist, leader, and mentor. [PDF]

Proc Natl Acad Sci U S A
Andrews NC, Daley GQ.
europepmc   +1 more source

Molecular Epidemiological Surveillance of HIV-1 Genotypes and Drug Resistance Profiles in Wuhan, Central China. [PDF]

Viruses
Zhang Q, Yan M, Huang J, Liu Y, Wang H, Feng S, Dong Z, Abulimiti D, Wang Y, Liang K, Feng Y.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

HIV nucleoside reverse transcriptase inhibitors

European Journal of Medicinal Chemistry, 2022
More than 40 years into the pandemic, HIV remains a global burden and as of now, there is no cure in sight. Fortunately, highly active antiretroviral therapy (HAART) has been developed to manage and suppress HIV infection. Combinations of two to three drugs targeting key viral proteins, including compounds inhibiting HIV reverse transcriptase (RT ...
Franck, Amblard, Dharmeshkumar, Patel, Eleftherios, Michailidis, Steven J, Coats, Mahesh, Kasthuri, Nicolas, Biteau, Zahira, Tber, Maryam, Ehteshami, Raymond F, Schinazi   +8 more
openaire   +2 more sources

HIV-1 reverse transcriptase inhibitors

Applied Microbiology and Biotechnology, 2007
Reverse transcriptase (RT) is one of the three enzymes encoded by the human immunodeficiency virus type 1 (HIV-1), the etiological agent of AIDS. Together with protease inhibitors, drugs inhibiting the RNA- and DNA-dependant DNA polymerase activity of RT are the major components of highly active antiretroviral therapy (HAART), which has dramatically ...
El Safadi, Yazan, Vivet-Boudou, Valérie, Marquet, Roland   +2 more
openaire   +3 more sources